1. Home
  2. Health
  3. Lupus
Lupus Blog

FromJeri Jewett-Tennant, MPH, Former About.com Guide to Lupus

New lupus drug Benlysta passes second clinical trial

Wednesday November 4, 2009

The LA Times is reporting that Benlysta, a new drug designed to treat lupus, has passed an important second clinical trial. The drug's maker, Human Genome Sciences, plans to apply for FDA approval next year. If approved, Benlysta will be the first new treatment for lupus in 50 years.

In the clinical trial, 43.2% of patients who took Benlysta in addition to their usual treatment saw their symptoms reduced, compared to 33.8% of people on a placebo.

Explore Lupus
About.com Special Features

A Balanced Life

Bring your life into balance with tips on good nutrition, family fun, and healthy activities. More >

8 Ways to Cut Drug Costs

Keep yourself, and your family, happy and healthy this season. More >

  1. Home
  2. Health
  3. Lupus

©2010 About.com, a part of The New York Times Company.

All rights reserved.